Home » Archive

Headline, Medical Device, SDBN Blog, SDBN Events »

SDBN June 23rd Networking Event Featuring Advanced BioHealing

Posted by Mary Canady May 31st, 2010 .
No Comments

Advanced BioHealing (ABH) is a great local company that has turned their product for diabetic foot ulcers, Dermagraft, into a success story for regenerative medicine. I met them at the BIO convention in May and wrote a blog post about their work. They really impressed me, and we thought SDBN members would be interested in hearing their story. ABH doesn’t fit neatly into a single category (perhaps somewhere between medical devices and stem cells, according to the ‘buckets’ we used in our 2010 poll), but perhaps that is part of …

More...

Biotechnology, Channels, Conferences, Drug Development, Featured, SDBN Blog »

Flip This Asset: San Diego’s Advanced BioHealing ‘Fixed Up’ Dermagraft for Profit and Growth #BIO2010

Posted by Mary Canady May 5th, 2010 .
No Comments

Wednesday I attended a regenerative medicine-focused breakfast at the BIO convention and learned about San Diego company Advanced BioHealing (ABH), who took a ‘fallen’ asset, Dermagraft, and not only turned it into an $85M/year product, but is also looking for new indications. Dermagraft was sold by Advanced Tissue Sciences, who had invested hundreds of millions into developing it, and even got FDA approval for the product to treat diabetic foot ulcers.
I spoke with Advanced BioHealing’s Senior VP Dean Tozer, and he describes their methodology as ‘reverse biotech,’ meaning that they …

More...

Biotechnology, Conferences, Drug Development, Featured, SDBN Blog »

How Does Biomarker Stratification Affect Drug Development Cost? It Depends. #BIO2010

Posted by Mary Canady May 5th, 2010 .
No Comments

On the San Diego Biotechnology Network LinkedIn group, we asked you what you wanted to hear about from the BIO Convention in Chicago, and you requested to hear about Biomarkers. Tuesday I attended a breakout session titled ‘Impact of Biomarkers on Drug Development Complexity and Cost,’ and it described a study done by panel members Federico Goodsaid of the FDA, Michael Palmer of Adaptive Pharmacogenomics, Mark Trusheim of MIT, Steven Averbuch of BMS, Theresa Long of the Van Andel Institute. The study modeled different scenarios utilizing biomarker information and the …

More...

Biotechnology, Channels, Conferences, Featured, SDBN Blog »

Translational Research Forum at #BIO2010: Learning From the Land of Lincoln

Posted by Mary Canady May 4th, 2010 .
No Comments

I attended the translational research forum Monday morning at the BIO 2010 convention in Chicago. The morning started with Congressman Dan Lipinski from Illinois, who was a great choice as he is a member of the House Committee for Science and Technology, as well as the House Committee on Small Business. He is sponsoring the NSF Reauthorization Bill, which will increase the NSF budget to $20B by 2015 and include funding for higher risk/reward projects. The bill will also have provisions for research infrastructure and education. This bill is slated …

More...

Drug Development, SDBN Blog, SDBN Events, SDBN Feed »

San Diego Biotechnology Network Partner Event May 27th: Rondaxe Drug Development Symposium

Posted by Mary Canady April 22nd, 2010 .
No Comments

Drug development is an area that, according to our 2010 poll, you are interested in, and in previous meetings we’ve discussed that San Diego biotech could grow if we would better complement our drug discovery capabilities with drug development. The SDBN was approached by Rondaxe, a drug development services company, with an idea for an event which will highlight companies they work with from outside the San Diego region. The event will be held May 27th, from 9:00 a.m. to 2:15 p.m., and a light breakfast and lunch will be …

More...

Channels, Conferences, Drug Discovery, Featured, SDBN Blog, Uncategorized »

SBS Day Two: A Holistic Approach To Drug Discovery #sbs10

Posted by Mary Canady April 14th, 2010 .
No Comments

I’m blogging from the Society for Biomolecular Sciences conference in Phoenix, the organizers were kind enough to offer two of us complimentary passes. I was surprised that the sessions were separated into disease area, technique, or ‘phenomenon’ (e.g., epigenetics) which seemed a bit curious as well, as I had expected the different types of assay technologies would have been the basis (e.g. HTS, Cell-based). It will be interesting to see how this changes if SBS merges with ALA. Nevertheless, I’ve been spending most of my time in the oncology session, …

More...

Channels, Featured, SDBN Blog »

SDBN Channels: Contribute, Interact, Learn

Posted by Mary Canady April 13th, 2010 .
No Comments

One thing I’ve learned from starting businesses/groups, is that your grand plans don’t always happen right away, but that they are eventually realized. We started the ‘main’ SDBN group on LinkedIn in order to give members a place to interact and connect, but it has limitations. Here, on the SDBN blog, we can do whatever we want, and the site is built upon WordPress which is infinitely customizable–we can allow anyone to blog here, add forums, etc. The result? We can help to grow San Diego Biotech in new, exciting …

More...

Drug Discovery »

Drug Discovery Channel–Welcome

Posted by Mary Canady April 11th, 2010 .
No Comments

We are launching channels on the San Diego Biotechnology Network, where local scientists and biotechnology professionals will be able to blog and discuss the topic. Our first posts will be from the Society for Biomolecular Sciences conference in Phoenix, stay tuned!

More...

Featured, SDBN Blog »

Blog About Drug Discovery for SDBN at SBS in Phoenix, Get in Free!

Posted by Mary Canady March 2nd, 2010 .
No Comments

Drug discovery is obviously a very hot topic for the San Diego biotech industry as we excel at it on so many levels. Many consider the Society for Biomolecular Sciences (SBS) annual conference to be the premier conference for drug discovery, and we are lucky that it will be held a short drive/flight away in Phoenix, Arizona this year April 11-15.
The conference organizers are also offering us a handful of FREE passes for those who would like to cover the conference through posts on the SDBN blog. Bloggers will still …

More...

Events »

ACS March Meeting

Posted by Mary Canady February 27th, 2010 .
No Comments

Title: Adulterants, APIs and Quality Challenges in Dietary Supplements
Speaker: Dr. William B. Martin, Ph.D.
Location: Celgene Corporation
March 18th, 2010
6:00-9:00 p.m.
RSVP: By Monday, March 15, 2010
[[Click here for more information.]]

More...